From the Journals

Antidepressant use linked to increased weight gain


 

FROM THE BMJ

Taking antidepressants appears associated with weight gain in a recent study, though the researchers caution that the link might not be causal. Antidepressant use already was lowest in those with an initially normal BMI, and it increased with each category of greater BMI.

“Participants of normal weight showed an increased risk of transitioning to overweight or obesity, and overweight participants were more likely to become obese if they were treated with an antidepressant,” Rafael Gafoor, PhD, of King’s College London, and his associates wrote in BMJ.

“The risk of weight gain was substantially increased during the second and third years of treatment,” they reported. “The risk of weight gain remained increased during at least 6 years of follow-up.”

The researchers retrospectively analyzed EHRs from the U.K. Clinical Practice Research Datalink, representing about 7% of general practices in the United Kingdom, to compare the risk of weight gain among those who were and were not prescribed antidepressants. Of more than 2 million registered participants, a random sample of those with at least three measurements for body mass index (BMI), representing different weight classes, were included.

Out of 136,762 men and 157,957 women, 13% of the men and 22.4% of the women received prescriptions for antidepressants. The 10-year follow-up period included more than 1.8 million person-years. The proportion of people gaining at least 5% in BMI was 11.1% in those with antidepressants prescriptions, compared with 8.1% in those not prescribed antidepressants.

“Antidepressant use was greater in patients with comorbidity and coprescriptions, particularly with diagnoses of stroke and diabetes or coprescribing of antiepileptics or antipsychotics, than in those without,” the researchers wrote. “Antidepressant use was also associated with current smoking and higher deprivation category.”

The researchers adjusted the analysis to account for age, sex, initial BMI classification, smoking, prescriptions for antiepileptics or antipsychotics, year, region of residence, socioeconomic status, or having received advice on weight management or diet. They also accounted for diabetes, coronary heart disease, stroke, cancer, and depression diagnoses, and they eliminated the 280 days before a newborn delivery to account for pregnancy-related weight increases.

Pages

Recommended Reading

Hormone therapy may reduce depressive symptoms in early menopause
Clinician Reviews
Serotonin syndrome warnings magnify its rare probability
Clinician Reviews
Serotonin syndrome risk with triptans and antidepressants ‘very low’
Clinician Reviews
Depression risks identified in women
Clinician Reviews
Suicide prevention, NRA team up for safer gun storage
Clinician Reviews
Ketamine formulation study is ‘groundbreaking’
Clinician Reviews
VIDEO: Novel postpartum depression drug effective in phase 3 trial
Clinician Reviews
Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models
Clinician Reviews
Adolescent suicidal ideation and attempts are on the rise
Clinician Reviews
Heart rate variability may be risk factor for depression, not a consequence
Clinician Reviews